- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06532786
Neural Adaptations to Metronome-Paced Strength Training
January 14, 2026 updated by: Egas Moniz - Cooperativa de Ensino Superior, CRL
Neural Adaptations to Metronome-Paced Strength Training: Insights From Neuroscience and Human Movement Variability
The aim of the study is to investigate the effects of incorporating variability within Resistance Training (RT) methods on the neural adaptations along the corticospinal tract and on neuromuscular function.
The literature suggests that RTis one of the most common modalities to enhance and restore muscle function and its practice results in adaptation in neural and morphological adaptations.
It is also known that conditions such as ageing and injury have a negative impact on neural drive to the muscles with consequences at motor control level that are not addressed by traditional RT.
Recent approaches such as metronome paced strength training have been used to cover this motor control dimension through a greater control and consciousness of movement.
However, this methodology tends not to incorporate the inherent variability and complex, fractal-like fluctuations that characterize human movement.
The investigators propose that incorporating variability through a fractal-like metronome approach will speed up the neural adaptations which will be useful in injury rehab.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: João H Oliveira, MSc
- Phone Number: +351 913266232
- Email: joao.henriques.oliveira@gmail.com
Study Contact Backup
- Name: João R Vaz, PhD
- Phone Number: +351 967096444
- Email: jvaz@egasmoniz.edu.pt
Study Locations
-
-
Monte de Caparica
-
Almada, Monte de Caparica, Portugal, 2829-699
- Recruiting
- Egas Moniz School of Health & Science
-
Contact:
- João R. Vaz, PhD
- Phone Number: +351 967096444
- Email: jvaz@egasmoniz.edu.pt
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- aged between 18 and 40 years
Exclusion Criteria:
- Neurologic conditions;
- Lower limb disabilities or disease;
- Not able to provide informed consent;
- Have an implanted device (e.g. pacemakers) or any metal in the body;
- Medication advised against the application of Transcranial Magnetic Stimulation;
- History/family history of seizures, brain lesions or head trauma, neurological or psychiatric diseases, epilepsy, migraine
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Fractal Paced
Strength training in single leg extension machine, synchronizing each repetition with a fractal-like visual metronome, i.e., a metronome presenting visual external cues with variability within its temporal structure.
|
The intervention consists in a metronome-paced strength training session performed 3 times per week (with 48h of rest between sessions), during 4 weeks.
Each session consists in 4 sets of 15 repetitions at 65% of the one-repetition maximal (1RM) in single leg extension machine, synchronizing each repetition with fractal external cues presented by a visual metronome.
The rest between sets will be set at 2 minutes of rest between sets.
|
|
Experimental: Isochronous Paced
Strength training in single leg extension machine, synchronizing each repetition with a isochronus visual metronome, i.e., a metronome presenting visual external cues withthe same pace in each repetition (without variability)
|
The intervention consists in a metronome-paced strength training session performed 3 times per week (with 48h of rest between sessions), during 4 weeks.
Each session consists in 4 sets of 15 repetitions at 65% of the one-repetition maximal (1RM) single in leg extension machine, synchronizing each repetition with isochronus external cues presented by a visual metronome.
The rest between sets will be set at 2 minutes of rest between sets.
|
|
Experimental: Self Paced
Strength training in single leg extension machine at participants self pace.
|
The intervention consists in a metronome-paced strength training session performed 3 times per week (with 48h of rest between sessions), during 4 weeks.
Each session consists in 4 sets of 15 repetitions at 65% of the one-repetition maximal (1RM) in single leg extension machine, at their own self pace (with no metronome).
The rest between sets will be set at 2 minutes of rest between sets.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Corticospinal Excitability (CSE) changes across the 4-weeks intervention (PRE to Week1, Week 2, Week 3, POST and follow-up) both within and between Fractal paced, Isochronus Paced and Self paced groups
Time Frame: PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
CSE is a parameter extracted through the application of Transcranial Magnetic Stimulation (TMS).
This parameter provides information regarding the level of excitability of the corticospinal tract.
|
PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
|
Short-interval Intracortical Inhibition (SICI) changes across the 4-weeks intervention (PRE to Week1, Week 2, Week 3, POST and follow-up) both within and between Fractal paced, Isochronus Paced and Self paced groups
Time Frame: PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
SICI is a parameter extracted through the application of Transcranial Magnetic Stimulation (TMS).
This parameter provides information regarding the level of inhibition within the motor cortex.
|
PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
|
Corticospinal Silent Period (CSP) changes across the 4-weeks intervention (PRE to Week1, Week 2, Week 3, POST and follow-up) both within and between Fractal paced, Isochronus Paced and Self paced groups
Time Frame: PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
CSP is a parameter extracted through the application of Transcranial Magnetic Stimulation (TMS).
This parameter provides information regarding the level of inhibition along the corticospinal tract.
|
PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
|
Intracortical Facilitation (ICF) changes across the 4-weeks intervention (PRE to Week1, Week 2, Week 3, POST and follow-up) both within and between Fractal paced, Isochronus Paced and Self paced groups
Time Frame: PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
ICF is a parameter extracted through the application of Transcranial Magnetic Stimulation (TMS).
This parameter provides information regarding the level of facilitation within the motor cortex.
|
PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
|
Lumbar Evoked Potentials (LEP) changes across the 4-weeks intervention (PRE to Week1, Week 2, Week 3, POST and follow-up) both within and between Fractal paced, Isochronus Paced and Self paced groups
Time Frame: PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
LEP is a measure extracted through the aplication of Lumbar stimulation.
This measure allow to distinguish the adaptations that occur at spinal level as a result of strength training.
|
PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
|
Maximal Compound Action Potentials (Mmax) changes across the 4-weeks intervention (PRE to Week1, Week 2, Week 3, POST and follow-up) both within and between Fractal paced, Isochronus Paced and Self paced groups
Time Frame: PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
Mmax is a measure assessed through peripheral nerve stimulation and represents the maximal capacity of recruit the motoneurons that innerve a muscle.
|
PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
|
StartReact Gain changes across the 4-weeks intervention (PRE to Week1, Week 2, Week 3, POST and follow-up) both within and between Fractal paced, Isochronus Paced and Self paced groups
Time Frame: PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
StartReact gain is a measure that is calculated following the StartReact protocol.
It consists in measuring the participants' reaction times in response to visual stimuli (visual reaction time [VRT]), visual stimuli combined with a quiet sound (visual auditory reaction time [VART]) and visual startling stimuli (visual startling reaction time [VSRT]) and, then, apply the following formula: StartReact gain = ([VRT - VSRT]/[VRT - VART]).
|
PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Single leg extension 1RM changes after 4-weeks intervention (PRE to POST and follow-up) both within and between Fractal paced, Isochronus Paced and Self paced groups
Time Frame: PRE (baseline), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
Single leg 1RM is defined as the maximal load that each participant mobilized in a single maximum dynamic knee extension.
|
PRE (baseline), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
|
Maximal Voluntary Isometric Contraction (MVIC) changes across the 4-weeks intervention (PRE to Week1, Week 2, Week 3, POST and follow-up) both within and between Fractal paced, Isochronus Paced and Self paced groups
Time Frame: PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
MVIC is defined as the maximal force an individual can produce against an immovable resistance
|
PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
|
Sample Entropy (SampEn) changes across the 4-weeks intervention (PRE to Week1, Week 2, Week 3, POST and follow-up) both within and between Fractal paced, Isochronus Paced and Self paced groups
Time Frame: PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
SampEn is a non-linear measure of the temporal structure of force output, being an indicator of the regularity of this physiological output.
It is obtained from sustained submaximal isometric contractions and it has been proposed as an indirect index of the capacity of the neuromuscular system to adapt the force output to changes in environment, i.e., its adaptability.
|
PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
|
Coefficient ov variation (CV) changes across the 4-weeks intervention (PRE to Week1, Week 2, Week 3, POST and follow-up) both within and between Fractal paced, Isochronus Paced and Self paced groups
Time Frame: PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
CV is a common linear measure that translates the amount of variability within the signal and is calculated through the standard deviation normalised to the mean of a time series
|
PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
|
Motor Unit Action Potentials (MUAP) changes across the 4-weeks intervention (PRE to Week1, Week 2, Week 3, POST and follow-up) both within and between Fractal paced, Isochronus Paced and Self paced groups
Time Frame: PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
MUAP is obtained through the decomposition of electromyographic (EMG) signals collected using High-density surface EMG electrodes and is an index of motor unit recruitment.
|
PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
|
Firing Rate (FR) changes across the 4-weeks intervention (PRE to Week1, Week 2, Week 3, POST and follow-up) both within and between Fractal paced, Isochronus Paced and Self paced groups
Time Frame: PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
FR is obtained through the decomposition of electromyographic (EMG) signals collected using High-density surface EMG electrodes and is a measure of intramuscular coordination
|
PRE (baseline), W1 (week 1), W2 (week 2), W3 (week 3), POST (week 4), FUP (follow-up 4 weeks after the end of intervention)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 15, 2024
Primary Completion (Estimated)
August 30, 2026
Study Completion (Estimated)
December 31, 2026
Study Registration Dates
First Submitted
July 29, 2024
First Submitted That Met QC Criteria
July 29, 2024
First Posted (Actual)
August 1, 2024
Study Record Updates
Last Update Posted (Estimated)
January 16, 2026
Last Update Submitted That Met QC Criteria
January 14, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- METROTRAIN - 1403
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
University of Vermont Medical CenterAvocado Nutrition CenterRecruitingHealthy | Healthy Volunteers | Healthy Subjects | Healthy Volunteer | Healthy Adult | Healthy Volunteers Only | Healthy Male and Female Subjects | Healthy Non-smokersUnited States
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
University of PalermoCompletedHealthy | Healthy Volunteers | Healthy Subjects | Healthy Participants | Static Stretching | Stretch | StretchingItaly
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
PfizerNot yet recruitingHealthy | Healthy AdultsUnited States
-
RAGE BioRecruitingHealthy | Healthy SmokerAustralia
Clinical Trials on Fractal Paced
-
Egas Moniz - Cooperativa de Ensino Superior, CRLFundação para a Ciência e a Tecnologia; University of EssexCompleted
-
Necmettin Erbakan UniversityCompleted
-
Recep Tayyip Erdogan University Training and Research...CompletedDental Caries in Children | Radiology | Pediatric PatientsTurkey
-
London Metropolitan UniversityCompleted
-
Egas Moniz - Cooperativa de Ensino Superior, CRLRecruitingAnterior Cruciate Ligament Reconstruction | Athlete | Anterior Cruciate Ligament Reconstruction RehabilitationPortugal
-
The Hong Kong Polytechnic UniversityUniversity of California, Berkeley; University of WaterlooCompletedVision, Balance and Falls in Older AdultsChina
-
University of California, San FranciscoCompleted
-
University of PittsburghBeckwith FoundationCompletedCongestive Heart FailureUnited States
-
Philips RespironicsCompletedSleep Apnea, ObstructiveUnited States